Venous Thromboembolism in Patients With Atrial Fibrillation

[1]  J. Weitz,et al.  State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism. , 2022, Thrombosis and haemostasis.

[2]  T. Chao,et al.  2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary , 2021, Thrombosis and Haemostasis.

[3]  A. Rosengren,et al.  Atrial fibrillation and risk of venous thromboembolism: a Swedish Nationwide Registry Study. , 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  A. Ruano-Raviña,et al.  Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor , 2020, Journal of thoracic disease.

[5]  L. Friberg,et al.  A diagnosis of atrial fibrillation is not a predictor for pulmonary embolism. , 2020, Thrombosis research.

[6]  G. Lip,et al.  Atrial fibrillation and the prothrombotic state: revisiting Virchow’s triad in 2020 , 2020, Heart.

[7]  M. Lamberts,et al.  Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study , 2019, BMC Cancer.

[8]  Yuanyuan Deng,et al.  Non–Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Cancer and Atrial Fibrillation: A Systematic Review and Meta‐Analysis , 2019, Journal of the American Heart Association.

[9]  D. Fitzmaurice,et al.  Early Risks of Death, Stroke/Systemic Embolism, and Major Bleeding in Patients With Newly Diagnosed Atrial Fibrillation: Results From the GARFIELD-AF Registry , 2019, Circulation.

[10]  L. Chen,et al.  Oral anticoagulation therapy and subsequent risk of venous thromboembolism in atrial fibrillation patients , 2018, Current medical research and opinion.

[11]  P. Lutsey,et al.  Atrial fibrillation and venous thromboembolism: evidence of bidirectionality in the Atherosclerosis Risk in Communities Study , 2018, Journal of thrombosis and haemostasis : JTH.

[12]  H. Bøtker,et al.  Risk of arterial and venous thromboembolism in patients with atrial fibrillation or flutter: A nationwide population-based cohort study. , 2017, International journal of cardiology.

[13]  M. Hernán,et al.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions , 2016, British Medical Journal.

[14]  A. Farcomeni,et al.  Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation. , 2015, American heart journal.

[15]  E. Mathiesen,et al.  Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study , 2015, Journal of thrombosis and haemostasis : JTH.

[16]  F. Sung,et al.  Atrial fibrillation associated with increased risk of venous thromboembolism , 2014, Thrombosis and Haemostasis.

[17]  Bernard J. Gersh,et al.  Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). , 2014, American heart journal.

[18]  E. Horváth-Puhó,et al.  Heart Disease May Be a Risk Factor for Pulmonary Embolism Without Peripheral Deep Venous Thrombosis , 2011, Circulation.

[19]  A. Członkowska,et al.  Early stroke-related deep venous thrombosis: risk factors and influence on outcome , 2011, Journal of Thrombosis and Thrombolysis.

[20]  D. Berlowitz,et al.  Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA) , 2010, Journal of thrombosis and haemostasis : JTH.

[21]  David J Spiegelhalter,et al.  A re-evaluation of random-effects meta-analysis , 2009, Journal of the Royal Statistical Society. Series A,.

[22]  D. Wilber,et al.  Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. , 2008, Journal of the American College of Cardiology.

[23]  P. Stein,et al.  Risk of venous thromboembolism in patients hospitalized with heart failure. , 2006, The American journal of cardiology.

[24]  A. Rudd,et al.  Venous Thromboembolism After Acute Ischemic Stroke: A Prospective Study Using Magnetic Resonance Direct Thrombus Imaging , 2004, Stroke.

[25]  A. Folsom,et al.  Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. , 2002, Archives of internal medicine.

[26]  G. Lip,et al.  Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. , 2001, European heart journal.

[27]  M. Howell,et al.  Congestive heart failure and outpatient risk of venous thromboembolism: a retrospective, case-control study. , 2001, Journal of clinical epidemiology.

[28]  Y. Kagaya,et al.  Increased von Willebrand factor in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. , 2001, Journal of the American College of Cardiology.

[29]  W M O'Fallon,et al.  Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. , 1998, Archives of internal medicine.

[30]  P. Lehert,et al.  Atrial fibrillation as a risk factor for deep venous thrombosis and pulmonary emboli in stroke patients. , 1991, Stroke.

[31]  C. Warlow,et al.  Deep venous thrombosis of the legs after strokes. Part I--incidence and predisposing factors. , 1976, British medical journal.

[32]  G. Lip,et al.  Adherence to the ‘Atrial Fibrillation Better Care’ Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes—A Systematic Review and Meta-Analysis of 285,000 Patients , 2021, Thrombosis and Haemostasis.

[33]  G. Rennert,et al.  CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation. , 2014, The American journal of medicine.

[34]  Cecilia Becattini,et al.  Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.